The global pharmacovigilance market is expected to grow at a compound annual growth rate of 11.24% over the forecast period to reach a market size of US$8.674 billion in 2026 from US$4.115 billion in 2019. The rising worldwide pervasiveness of ADRs will build interest in the pharmacovigilance market.